- Home
- BLRX vs UCL Comparison
BLRX vs UCL Comparison
Compare BLRX & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- UCL
- Stock Information
- Founded
- BLRX 2003
- UCL 2014
- Country
- BLRX Israel
- UCL Hong Kong
- Employees
- BLRX N/A
- UCL N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- UCL Telecommunications Equipment
- Sector
- BLRX Health Care
- UCL Consumer Discretionary
- Exchange
- BLRX Nasdaq
- UCL Nasdaq
- Market Cap
- BLRX 54.1M
- UCL 48.4M
- IPO Year
- BLRX 2011
- UCL 2020
- Fundamental
- Price
- BLRX $0.46
- UCL $1.19
- Analyst Decision
- BLRX Strong Buy
- UCL
- Analyst Count
- BLRX 2
- UCL 0
- Target Price
- BLRX $11.50
- UCL N/A
- AVG Volume (30 Days)
- BLRX 301.3K
- UCL 21.4K
- Earning Date
- BLRX 11-18-2024
- UCL 11-13-2024
- Dividend Yield
- BLRX N/A
- UCL N/A
- EPS Growth
- BLRX N/A
- UCL N/A
- EPS
- BLRX N/A
- UCL 0.12
- Revenue
- BLRX $17,048,000.00
- UCL $86,076,000.00
- Revenue This Year
- BLRX N/A
- UCL $11.23
- Revenue Next Year
- BLRX N/A
- UCL $27.52
- P/E Ratio
- BLRX N/A
- UCL $10.82
- Revenue Growth
- BLRX N/A
- UCL 10.63
- 52 Week Low
- BLRX $0.44
- UCL $1.16
- 52 Week High
- BLRX $1.93
- UCL $2.96
- Technical
- Relative Strength Index (RSI)
- BLRX 31.51
- UCL 37.17
- Support Level
- BLRX $0.44
- UCL $1.16
- Resistance Level
- BLRX $0.56
- UCL $1.29
- Average True Range (ATR)
- BLRX 0.05
- UCL 0.07
- MACD
- BLRX -0.01
- UCL -0.00
- Stochastic Oscillator
- BLRX 22.39
- UCL 11.11
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.